Diabetic eye disease: The urgent need for early, non-invasive treatments
Drug Discovery World
MAY 15, 2024
Currently in a Phase Ib/IIa study, it is believed to stabilise GAP-junction activity through regulation of connexin-43. million diagnosed cases of diabetic retinopathy in the nine major pharmaceutical markets, expected to grow to >17.7 million by 2029, according to GlobalData. In 2019 there were >14.2 2019;85(2):347-355.
Let's personalize your content